企業プロフィール
Exicure 株価・ニュース・カタリスト
- ティッカー:
- XCUR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.15 USD (-11.54%)
終値
最終更新: 2026年8月21日
19.8M USD
時価総額
株価変動の要因
As of Aug 21, 2026, XCUR closed down 11.5% at $1.15. No new same-company headline was identified in the current news window.
企業概要
Early-Stage Biopharmaceutical Operations
Exicure is rebuilding a research and development business following the acquisition of GPCR Therapeutics USA. The company has limited liquidity and is simultaneously evaluating financing and strategic alternatives.
Stem-Cell Mobilization Program
Its lead development program is being evaluated for improving stem-cell mobilization in multiple myeloma and sickle cell disease and for supporting cell and gene therapy procedures. The source disclosure does not provide a named candidate or development timetable.
今後のカタリスト
- Exicure is largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone. The market is focused on what remains.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。